Edition:
United States

TESARO Inc (TSRO.OQ)

TSRO.OQ on NASDAQ Stock Exchange Global Select Market

27.01USD
3:59pm EST
Change (% chg)

$1.91 (+7.61%)
Prev Close
$25.10
Open
$25.11
Day's High
$27.27
Day's Low
$24.78
Volume
923,150
Avg. Vol
494,850
52-wk High
$91.75
52-wk Low
$23.50

Chart for

About

TESARO, Inc. is an oncology-focused biopharmaceutical company. The Company operates through the business of developing and commercializing of oncology-focused therapeutics segment. It is developing oncology-related product candidates, including rolapitant, niraparib and the product candidates under its immuno-oncology platform.... (more)

Overall

Beta: 1.29
Market Cap(Mil.): $1,381.68
Shares Outstanding(Mil.): 55.05
Dividend: --
Yield (%): --

Financials

  TSRO.OQ Industry Sector
P/E (TTM): -- 81.01 29.57
EPS (TTM): -11.91 -- --
ROI: -120.71 -0.53 12.77
ROE: -469.05 -3.22 14.47

UPDATE 2-European shares enjoy timid rebound though trade war fears linger

* France's CAC 40 underperforms as luxury stocks fall (Updates prices, adds details)

Jun 20 2018

BRIEF-Tesaro Announces Collaboration To Evaluate Zejula In Combination With Anti-PD-L1 Cancer Immunotherapy, MEK Inhibitor In Platinum-Sensitive Ovarian Cancer

* TESARO ANNOUNCES COLLABORATION TO EVALUATE ZEJULA® IN COMBINATION WITH ANTI-PD-L1 CANCER IMMUNOTHERAPY AND MEK INHIBITOR IN PLATINUM-SENSITIVE OVARIAN CANCER

Jun 05 2018

Earnings vs. Estimates